+Search query
-Structure paper
Title | LSD1 enzyme inhibitor TAK-418 unlocks aberrant epigenetic machinery and improves autism symptoms in neurodevelopmental disorder models. |
---|---|
Journal, issue, pages | Sci Adv, Vol. 7, Year 2021 |
Publish date | Jan 28, 2021 (structure data deposition date) |
Authors | Baba, R. / Matsuda, S. / Arakawa, Y. / Yamada, R. / Suzuki, N. / Ando, T. / Oki, H. / Igaki, S. / Daini, M. / Hattori, Y. ...Baba, R. / Matsuda, S. / Arakawa, Y. / Yamada, R. / Suzuki, N. / Ando, T. / Oki, H. / Igaki, S. / Daini, M. / Hattori, Y. / Matsumoto, S. / Ito, M. / Nakatani, A. / Kimura, H. |
External links | Sci Adv / PubMed:33712455 |
Methods | X-ray diffraction |
Resolution | 2.25 Å |
Structure data | PDB-7e0g: |
Chemicals | ChemComp-HUF: ChemComp-GOL: ChemComp-IMD: ChemComp-MG: ChemComp-HOH: |
Source |
|
Keywords | OXIDOREDUCTASE / Inhibitor / TAK-418 / FAD-adduct |